688289 圣湘生物
已收盘 05-08 15:00:01
资讯
新帖
简况
股市必读:圣湘生物年报 - 第四季度单季净利润同比下降90.50%
证券之星 · 05-06
股市必读:圣湘生物年报 - 第四季度单季净利润同比下降90.50%
每周股票复盘:圣湘生物(688289)一季度净利降45.78%
证券之星 · 05-02
每周股票复盘:圣湘生物(688289)一季度净利降45.78%
圣湘生物(688289)披露2025年年度报告全文,4月30日股价下跌1.55%
证券之星 · 04-30
圣湘生物(688289)披露2025年年度报告全文,4月30日股价下跌1.55%
图解圣湘生物年报:第四季度单季净利润同比下降90.50%
证券之星 · 04-30
图解圣湘生物年报:第四季度单季净利润同比下降90.50%
每周股票复盘:圣湘生物(688289)拟发行不超10亿元中期票据
证券之星 · 04-19
每周股票复盘:圣湘生物(688289)拟发行不超10亿元中期票据
圣湘生物(688289)披露拟注册发行不超过10亿元中期票据,4月15日股价下跌0.16%
证券之星 · 04-15
圣湘生物(688289)披露拟注册发行不超过10亿元中期票据,4月15日股价下跌0.16%
每周股票复盘:圣湘生物(688289)拟注册发行中期票据
证券之星 · 04-12
每周股票复盘:圣湘生物(688289)拟注册发行中期票据
圣湘生物(688289.SH)拟注册发行不超10亿元中期票据
智通财经 · 04-07
圣湘生物(688289.SH)拟注册发行不超10亿元中期票据
每周股票复盘:圣湘生物(688289)临时股东会通过对外投资议案
证券之星 · 04-05
每周股票复盘:圣湘生物(688289)临时股东会通过对外投资议案
圣湘生物(688289)披露关于与关联方共同投资华斯无微生物科技(深圳)有限公司的议案,4月3日股价下跌2.63%
证券之星 · 04-03
圣湘生物(688289)披露关于与关联方共同投资华斯无微生物科技(深圳)有限公司的议案,4月3日股价下跌2.63%
圣湘生物最新公告:拟与关联方共同投资设立合资公司并收购华斯无微100%股权
中金财经 · 03-15
圣湘生物最新公告:拟与关联方共同投资设立合资公司并收购华斯无微100%股权
圣湘生物(688289)披露与关联方共同投资北京哲源科技公告,3月13日股价上涨0.38%
证券之星 · 03-13
圣湘生物(688289)披露与关联方共同投资北京哲源科技公告,3月13日股价上涨0.38%
圣湘生物新注册《两方径向基核函数计算的隐私保护软件V1.0》等5个项目的软件著作权
证券之星 · 03-07
圣湘生物新注册《两方径向基核函数计算的隐私保护软件V1.0》等5个项目的软件著作权
圣湘生物(688289)披露2025年度业绩快报公告,3月2日股价下跌3.65%
证券之星 · 03-02
圣湘生物(688289)披露2025年度业绩快报公告,3月2日股价下跌3.65%
每周股票复盘:圣湘生物(688289)2025年净利降28.10%
证券之星 · 03-01
每周股票复盘:圣湘生物(688289)2025年净利降28.10%
圣湘生物最新公告:控股子公司产品新增适应症获得临床试验批准
证券之星 · 02-26
圣湘生物最新公告:控股子公司产品新增适应症获得临床试验批准
1月28日圣湘生物跌6.56%,银河医药混合A基金重仓该股
中金财经 · 01-28
1月28日圣湘生物跌6.56%,银河医药混合A基金重仓该股
1月26日圣湘生物涨8.97%,银河医药混合A基金重仓该股
证券之星 · 01-26
1月26日圣湘生物涨8.97%,银河医药混合A基金重仓该股
圣湘生物(688289)披露2023年第二期限制性股票激励计划首次授予部分第一个归属期归属结果公告,12月19日股价上涨0.26%
证券之星 · 2025-12-19
圣湘生物(688289)披露2023年第二期限制性股票激励计划首次授予部分第一个归属期归属结果公告,12月19日股价上涨0.26%
圣湘生物(688289)披露相关产品取得医疗器械注册证,12月16日股价下跌1.96%
证券之星 · 2025-12-16
圣湘生物(688289)披露相关产品取得医疗器械注册证,12月16日股价下跌1.96%
加载更多
公司概况
公司名称:
圣湘生物科技股份有限公司
所属行业:
医药制造业
上市日期:
2020-08-28
主营业务:
圣湘生物科技股份有限公司的主营业务是诊断试剂和仪器的研发、生产、销售,以及第三方医学检验服务。公司的主要产品是诊断试剂、诊断仪器、生物类药品、检测服务。公司是国家基因检测技术应用示范中心、感染性疾病及肿瘤基因诊断技术国家地方联合工程研究中心、国家企业技术中心、国家技术创新示范企业、国家级博士后科研工作站单位、国家知识产权示范企业,荣获国家科技进步二等奖、中国专利银奖等60余项国内外重大奖项,承担国家“十三五”“十四五”等重大项目60余项。
发行价格:
50.48
{"stockData":{"symbol":"688289","market":"SH","secType":"STK","nameCN":"圣湘生物","latestPrice":18.12,"timestamp":1778223601000,"preClose":17.46,"halted":0,"volume":11452021,"delay":0,"changeRate":0.0378,"floatShares":579000000,"shares":579000000,"eps":0.2709,"marketStatus":"已收盘","change":0.66,"latestTime":"05-08 15:00:01","open":17.5,"high":18.31,"low":17.5,"amount":207000000,"amplitude":0.0464,"askPrice":18.13,"askSize":107,"bidPrice":18.12,"bidSize":671,"shortable":0,"etf":0,"ttmEps":0.2709,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778463000000},"marketStatusCode":5,"adr":0,"adjPreClose":17.46,"symbolType":"stock_kcb","openAndCloseTimeList":[[1778203800000,1778211000000],[1778216400000,1778223600000]],"highLimit":19.21,"lowLimit":15.71,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":579388006,"isCdr":false,"pbRate":1.47,"roa":"--","peRate":66.888151,"roe":"0.69%","epsLYR":0.34,"committee":0.15995,"marketValue":10499000000,"turnoverRate":0.0198,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-05-11。","afterMarket":{"amount":21744,"volume":1200,"close":18.12,"buyVolume":6160,"sellVolume":0,"time":1778225637558,"indexStatus":"已收盘 05-08 15:30:00","preClose":17.46},"floatMarketCap":10499000000},"requestUrl":"/m/hq/s/688289/","defaultTab":"news","newsList":[{"id":"2633921390","title":"股市必读:圣湘生物年报 - 第四季度单季净利润同比下降90.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633921390","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633921390?lang=zh_cn&edition=full","pubTime":"2026-05-06 04:22","pubTimestamp":1778012530,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,圣湘生物报收于17.15元,下跌1.55%,换手率0.7%,成交量4.06万手,成交额6960.94万元。来自:2025年公司归母净利润1.99亿元,同比下降27.82%;第四季度单季净利润同比下滑90.5%。2025年第四季度单季度主营收入3.97亿元,同比下降6.6%;单季度归母净利润761.61万元,同比下降90.5%;单季度扣非净利润1003.51万元,同比下降80.29%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600003501.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632640906","title":"每周股票复盘:圣湘生物(688289)一季度净利降45.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632640906","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632640906?lang=zh_cn&edition=full","pubTime":"2026-05-02 04:50","pubTimestamp":1777668621,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,圣湘生物报收于17.15元,较上周的17.44元下跌1.66%。公司公告汇总圣湘生物科技股份有限公司2025年年度报告全文2025年公司实现营业收入16.42亿元,同比增长12.58%;归母净利润1.99亿元,同比下降27.82%;扣非净利润1.67亿元,同比下降17.52%。圣湘生物科技股份有限公司关于2025年度日常关联交易确认及预计2026年度日常关联交易的公告公司确认2025年度日常关联交易实际发生金额合计975.73万元,预计2026年度日常关联交易总额为10,119.38万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200002858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631568258","title":"圣湘生物(688289)披露2025年年度报告全文,4月30日股价下跌1.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631568258","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631568258?lang=zh_cn&edition=full","pubTime":"2026-04-30 17:50","pubTimestamp":1777542637,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,圣湘生物报收于17.15元,较前一交易日下跌1.55%,最新总市值为99.37亿元。该股当日开盘17.25元,最高17.25元,最低17.08元,成交额达6960.94万元,换手率为0.7%。近日,圣湘生物科技股份有限公司披露《2025年年度报告全文》。公告显示,公司2025年实现营业收入16.42亿元,同比增长12.58%;归属于上市公司股东的净利润为1.99亿元,同比下降27.82%;扣除非经常性损益后的净利润为1.67亿元,同比下降17.52%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000057898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631544244","title":"图解圣湘生物年报:第四季度单季净利润同比下降90.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631544244","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631544244?lang=zh_cn&edition=full","pubTime":"2026-04-30 01:04","pubTimestamp":1777482286,"startTime":"0","endTime":"0","summary":"证券之星消息,圣湘生物2025年年报显示,当年度公司主营收入16.42亿元,同比上升12.58%;归母净利润1.99亿元,同比下降27.82%;扣非净利润1.67亿元,同比下降17.52%;其中2025年第四季度,公司单季度主营收入3.97亿元,同比下降6.6%;单季度归母净利润761.61万元,同比下降90.5%;单季度扣非净利润1003.51万元,同比下降80.29%;负债率24.53%,投资收益-5523.78万元,财务费用-6407.57万元,毛利率75.79%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000003385.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628756790","title":"每周股票复盘:圣湘生物(688289)拟发行不超10亿元中期票据","url":"https://stock-news.laohu8.com/highlight/detail?id=2628756790","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628756790?lang=zh_cn&edition=full","pubTime":"2026-04-19 02:08","pubTimestamp":1776535689,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘,圣湘生物报收于17.9元,较上周的18.31元下跌2.24%。本周,圣湘生物4月15日盘中最高价报18.39元。本周关注点公司公告汇总:圣湘生物拟发行不超过10亿元中期票据,用于偿还有息负债、补充营运资金等用途。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900000672.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627023872","title":"圣湘生物(688289)披露拟注册发行不超过10亿元中期票据,4月15日股价下跌0.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627023872","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627023872?lang=zh_cn&edition=full","pubTime":"2026-04-15 22:19","pubTimestamp":1776262755,"startTime":"0","endTime":"0","summary":"截至2026年4月15日收盘,圣湘生物报收于18.26元,较前一交易日下跌0.16%,最新总市值为105.8亿元。该股当日开盘18.29元,最高18.39元,最低18.24元,成交额达4766.29万元,换手率为0.45%。近日,圣湘生物科技股份有限公司披露《2026年第二次临时股东会会议资料》。本次发行授权董事会全权办理相关事宜,授权有效期自股东会审议通过之日起,在注册和存续有效期内持续有效。该事项已由公司董事会审议通过,尚需交易商协会注册批准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500043117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626122613","title":"每周股票复盘:圣湘生物(688289)拟注册发行中期票据","url":"https://stock-news.laohu8.com/highlight/detail?id=2626122613","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626122613?lang=zh_cn&edition=full","pubTime":"2026-04-12 01:54","pubTimestamp":1775930053,"startTime":"0","endTime":"0","summary":"截至2026年4月10日收盘,圣湘生物报收于18.31元,较上周的17.76元上涨3.1%。本周,圣湘生物4月8日盘中最高价报18.53元。圣湘生物当前最新总市值106.09亿元,在医疗器械板块市值排名33/129,在两市A股市值排名1879/5196。本周关注点公司公告汇总:圣湘生物拟注册和发行中期票据,并召开临时股东会审议该议案。会议审议《关于拟注册和发行中期票据的议案》,对中小投资者单独计票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041200000470.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625895847","title":"圣湘生物(688289.SH)拟注册发行不超10亿元中期票据","url":"https://stock-news.laohu8.com/highlight/detail?id=2625895847","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625895847?lang=zh_cn&edition=full","pubTime":"2026-04-07 20:38","pubTimestamp":1775565510,"startTime":"0","endTime":"0","summary":"智通财经APP讯,圣湘生物(688289.SH)发布公告,公司拟向中国银行间市场交易商协会申请注册并发行不超过10亿元(含10亿元)的中期票据,并根据市场情况以及自身资金需求状况在注册额度内择机一次性或分期发行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425580.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625164136","title":"每周股票复盘:圣湘生物(688289)临时股东会通过对外投资议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2625164136","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625164136?lang=zh_cn&edition=full","pubTime":"2026-04-05 02:17","pubTimestamp":1775326629,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,圣湘生物报收于17.76元,较上周的18.28元下跌2.84%。本周关注点公司公告汇总:圣湘生物2026年第一次临时股东会审议通过与关联方共同投资华斯无微生物科技(深圳)有限公司的议案。圣湘生物科技股份有限公司于2026年3月31日召开2026年第一次临时股东会,会议由董事彭铸主持,采用现场与网络投票相结合方式召开。出席会议的股东共307人,代表有表决权股份总数56,971,929股,占公司表决权总数的9.9105%。关联股东未出席本次会议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500000520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624591736","title":"圣湘生物(688289)披露关于与关联方共同投资华斯无微生物科技(深圳)有限公司的议案,4月3日股价下跌2.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624591736","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624591736?lang=zh_cn&edition=full","pubTime":"2026-04-03 17:40","pubTimestamp":1775209229,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,圣湘生物报收于17.76元,较前一交易日下跌2.63%,最新总市值为102.9亿元。该股当日开盘18.19元,最高18.22元,最低17.75元,成交额达7054.79万元,换手率为0.68%。公告显示,公司于2026年3月31日召开2026年第一次临时股东会,审议通过《关于与关联方共同投资华斯无微生物科技(深圳)有限公司的议案》。关联股东未出席本次会议。湖南启元律师事务所对本次会议进行了见证并出具法律意见书,认为会议决议合法有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300034610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159837","HBImain","688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619059531","title":"圣湘生物最新公告:拟与关联方共同投资设立合资公司并收购华斯无微100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2619059531","media":"中金财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619059531?lang=zh_cn&edition=full","pubTime":"2026-03-15 18:24","pubTimestamp":1773570244,"startTime":"0","endTime":"0","summary":"圣湘生物(688289.SH)公告称,公司拟与关联方湖南金芙蓉圣湘生物股权投资基金合伙企业共同投资设立湖南圣维华斯生物技术有限公司,并将其作为后续收购华斯无微生物科技(深圳)有限公司100%股权的投资主体。其中,公司以自有资金出资6543.80万元,交易完成后,合资公司及华斯无微将纳入公司合并报表范围。为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260315/32069420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619198555","title":"圣湘生物(688289)披露与关联方共同投资北京哲源科技公告,3月13日股价上涨0.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619198555","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619198555?lang=zh_cn&edition=full","pubTime":"2026-03-13 17:23","pubTimestamp":1773393797,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘,圣湘生物报收于18.28元,较前一交易日上涨0.38%,最新总市值为105.91亿元。圣湘生物科技股份有限公司于近日披露《关于与关联方共同投资北京哲源科技有限责任公司的公告》。公告显示,公司拟与关联方湖南金芙蓉圣湘生物股权投资基金合伙企业共同投资北京哲源科技有限责任公司;圣湘生物以自有资金投资4,000.00万元,基金投资5,000.00万元,通过受让股权及增资后,公司将持有哲源科技4.02%的股权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300029637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617632340","title":"圣湘生物新注册《两方径向基核函数计算的隐私保护软件V1.0》等5个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2617632340","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617632340?lang=zh_cn&edition=full","pubTime":"2026-03-07 01:55","pubTimestamp":1772819716,"startTime":"0","endTime":"0","summary":"证券之星消息,近日圣湘生物新注册了5个项目的软件著作权,包括《两方径向基核函数计算的隐私保护软件V1.0》、《基于CKKS同态加密的LightGBM决策树推理软件V1.0》、《LightGBM 树结构聚类与填充软件V1.0》、《融合同态加密与多方安全计算的核支持向量机训练软件V1.0》、《基于同态加密的隐私保护主成分分析软件V1.0》等。今年以来圣湘生物新注册软件著作权5个,较去年同期增加了400%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030700000217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616138744","title":"圣湘生物(688289)披露2025年度业绩快报公告,3月2日股价下跌3.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616138744","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616138744?lang=zh_cn&edition=full","pubTime":"2026-03-02 17:36","pubTimestamp":1772444188,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘,圣湘生物报收于18.5元,较前一交易日下跌3.65%,最新总市值为107.19亿元。该股当日开盘18.99元,最高19.13元,最低18.5元,成交额达1.7亿元,换手率为1.57%。圣湘生物科技股份有限公司于近日披露《2025年度业绩快报公告》。公告显示,公司2025年营业总收入为16.48亿元,同比增长13.04%;营业利润为2.02亿元,同比下降27.13%;归属于母公司所有者的净利润为1.98亿元,同比下降28.10%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200025979.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616843955","title":"每周股票复盘:圣湘生物(688289)2025年净利降28.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616843955","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616843955?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:02","pubTimestamp":1772301738,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘,圣湘生物报收于19.2元,较上周的19.31元下跌0.57%。本周,圣湘生物2月25日盘中最高价报19.68元。圣湘生物当前最新总市值111.24亿元,在医疗器械板块市值排名33/129,在两市A股市值排名1920/5189。圣湘生物科技股份有限公司2025年度业绩快报显示,营业总收入16.48亿元,同比增长13.04%;营业利润2.02亿元,同比下降27.13%;归属于母公司所有者的净利润1.98亿元,同比下降28.10%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000578.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614012057","title":"圣湘生物最新公告:控股子公司产品新增适应症获得临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2614012057","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614012057?lang=zh_cn&edition=full","pubTime":"2026-02-26 18:39","pubTimestamp":1772102381,"startTime":"0","endTime":"0","summary":"圣湘生物(688289.SH)公告称,公司控股子公司中山圣湘海济生物医药有限公司的产品人生长激素注射液(商品名称:海之元)拟新增用于特发性矮身材(ISS)的适应症补充申请已获得国家药监局的临床试验批准。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600030511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606796031","title":"1月28日圣湘生物跌6.56%,银河医药混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2606796031","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606796031?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:49","pubTimestamp":1769590149,"startTime":"0","endTime":"0","summary":"证券之星消息,1月28日圣湘生物跌6.56%,收盘报20.67元,换手率4.87%,成交量28.21万手,成交额5.91亿元。重仓圣湘生物的公募基金请见下表:该股最近90天内共有2家机构给出评级,买入评级2家。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为银河基金的银河医药混合A。银河医药混合A目前规模为4.29亿元,最新净值0.6237,较上一交易日下跌0.94%,近一年上涨29.67%。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202601/28/20260128602037.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202601/28/20260128602037.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260128/31979473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688289","BK1161","09939","BK0239","BK1515","159938","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606895297","title":"1月26日圣湘生物涨8.97%,银河医药混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2606895297","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606895297?lang=zh_cn&edition=full","pubTime":"2026-01-26 15:41","pubTimestamp":1769413317,"startTime":"0","endTime":"0","summary":"证券之星消息,1月26日圣湘生物涨8.97%创60日新高,收盘报21.98元,换手率6.54%,成交量37.9万手,成交额8.26亿元。重仓圣湘生物的公募基金请见下表:该股最近90天内共有2家机构给出评级,买入评级2家。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为银河基金的银河医药混合A。银河医药混合A目前规模为4.29亿元,最新净值0.6321,较上一交易日上涨1.84%,近一年上涨31.41%。该公募基金现任基金经理为方伟。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600014977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK0239","BK1574","09939","BK1161","688289","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592916070","title":"圣湘生物(688289)披露2023年第二期限制性股票激励计划首次授予部分第一个归属期归属结果公告,12月19日股价上涨0.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592916070","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592916070?lang=zh_cn&edition=full","pubTime":"2025-12-19 22:18","pubTimestamp":1766153925,"startTime":"0","endTime":"0","summary":"截至2025年12月19日收盘,圣湘生物报收于19.18元,较前一交易日上涨0.26%,最新总市值为111.13亿元。近日,圣湘生物科技股份有限公司发布关于2023年第二期限制性股票激励计划首次授予部分第一个归属期归属结果的公告。公告显示,公司已完成该次激励计划首次授予部分第一个归属期的股份登记,本次归属股票数量为684,199股,来源为公司从二级市场回购的A股普通股股票。本次归属不导致公司总股本、控股股东及实际控制人持股比例发生变化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121900039125.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2591945980","title":"圣湘生物(688289)披露相关产品取得医疗器械注册证,12月16日股价下跌1.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591945980","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591945980?lang=zh_cn&edition=full","pubTime":"2025-12-16 22:12","pubTimestamp":1765894370,"startTime":"0","endTime":"0","summary":"截至2025年12月16日收盘,圣湘生物报收于18.51元,较前一交易日下跌1.96%,最新总市值为107.24亿元。公司近日发布公告称,圣湘生物科技股份有限公司的四款产品近日获得国家药品监督管理局颁发的《医疗器械注册证》。上述产品均为境内第三类体外诊断试剂,有效期至2030年12月11日。此次获批丰富了公司呼吸道感染快速检测体系,提升了EB病毒检测能力,并扩展了药物基因组学应用,有助于临床精准用药和疾病管理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600040620.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","09997","BK1222","159883","BK1574","BK1583","09996","BK1100","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778367892533,"stockEarnings":[{"period":"1week","weight":0.0566},{"period":"1month","weight":-0.0189},{"period":"3month","weight":-0.0926},{"period":"6month","weight":-0.1669},{"period":"1year","weight":-0.0792},{"period":"ytd","weight":-0.0418}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0463},{"period":"3month","weight":0.0281},{"period":"6month","weight":0.0456},{"period":"1year","weight":0.247},{"period":"ytd","weight":0.0532}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"圣湘生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"21493人(较上一季度增加7.68%)","perCapita":"26957股","listingDate":"2020-08-28","address":"湖南省长沙市岳麓区高新技术产业开发区麓松路680号","registeredCapital":"57938万元","survey":" 圣湘生物科技股份有限公司的主营业务是诊断试剂和仪器的研发、生产、销售,以及第三方医学检验服务。公司的主要产品是诊断试剂、诊断仪器、生物类药品、检测服务。公司是国家基因检测技术应用示范中心、感染性疾病及肿瘤基因诊断技术国家地方联合工程研究中心、国家企业技术中心、国家技术创新示范企业、国家级博士后科研工作站单位、国家知识产权示范企业,荣获国家科技进步二等奖、中国专利银奖等60余项国内外重大奖项,承担国家“十三五”“十四五”等重大项目60余项。","listedPrice":50.48},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"圣湘生物(688289)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供圣湘生物(688289)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"圣湘生物,688289,圣湘生物股票,圣湘生物股票老虎,圣湘生物股票老虎国际,圣湘生物行情,圣湘生物股票行情,圣湘生物股价,圣湘生物股市,圣湘生物股票价格,圣湘生物股票交易,圣湘生物股票购买,圣湘生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"圣湘生物(688289)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供圣湘生物(688289)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}